Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1553512

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1553512

Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report By Application (Pulmonary Stenosis, Pulmonary Regurgitation), By Technology, By End-use, By Raw Material, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Transcatheter Pulmonary Valve Market Growth & Trends:

The global transcatheter pulmonary valve market size is expected to reach USD 100.6 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2023, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

Transcatheter Pulmonary Valve Market Report Highlights:

  • Pulmonary stenosis dominated the market and accounted for a market share of 43.1% in 2023. TPV operations are less invasive in nature compared to open-heart surgery.
  • In 2023, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing transcatheter pulmonary valve market during the forecast period
  • Some of the key players are Boston Scientific Corporation, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, and VENUS MEDTECH.
Product Code: GVR-1-68038-702-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Pulmonary Valve Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transcatheter Pulmonary Valve Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transcatheter Pulmonary Valve Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transcatheter Pulmonary Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Pulmonary Stenosis
    • 4.3.1. Pulmonary Stenosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Pulmonary Regurgitation
    • 4.4.1. Pulmonary Regurgitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pulmonary Atresia
    • 4.5.1. Pulmonary Atresia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transcatheter Pulmonary Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transcatheter Pulmonary Valve Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ballon Expanded Transcatheter Valve
    • 5.3.1. Ballon Expanded Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Self Expanded Transcatheter Valve
    • 5.4.1. Self Expanded Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transcatheter Pulmonary Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transcatheter Pulmonary Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Adult
    • 6.3.1. Adult Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pediatric Transcatheter Valve
    • 6.4.1. Pediatric Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transcatheter Pulmonary Valve Market: Raw Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transcatheter Pulmonary Valve Market: Raw Material Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Synthetic
    • 7.3.1. Synthetic Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Tissue engineered
    • 7.4.1. Tissue engineered Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transcatheter Pulmonary Valve Market: Regional Estimates & Trend Analysis

  • 8.1. Transcatheter Pulmonary Valve Market Share, By Region, 2023 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Sweden Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Boston Scientific Corporation
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Braile Biomedica
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Artivion, Inc
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Edwards Lifesciences Corporation
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. JenaValve Technology, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. LivaNova PLC
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Medtronic
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Venus Medtech
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Lepu Medical Technology
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Jude Medical Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!